Skip to main content
Erschienen in: Pediatric Nephrology 6/2005

01.06.2005 | Original Article

C1q nephropathy: features at presentation and outcome

verfasst von: Keith K. Lau, Lillian W. Gaber, Noel M. Delos Santos, Robert J. Wyatt

Erschienen in: Pediatric Nephrology | Ausgabe 6/2005

Einloggen, um Zugang zu erhalten

Abstract

The study population comprised all 20 patients followed since 1990 through December 2004 at the Le Bonheur Children’s Medical Center with diagnosis of C1q nephropathy (55% boys; 60% African Americans). All were aged under 18 years at biopsy (mean 11.2 years, 65% aged 11 or over); the youngest presented at age 10 months and progressed to end-stage renal disease at 14 months. None had clinical or laboratory features of systemic lupus erythematosis or membranoproliferative glomerulonephritis. Clinical features assessed at diagnosis were age, gender, blood pressure, history of macroscopic hematuria, urinary protein to creatinine ratio, serum creatinine, estimated glomerular filtration rate, renal histology, and pattern for immunofluorescent reactants. At the time of biopsy 40% had nephrotic syndrome and 30% nephrotic range proteinuria without nephrotic syndrome. Three patients with nephrotic syndrome also had chronic renal insufficiency at diagnosis. The most common histological feature was focal segmental glomerulosclerosis in 40%, but 30% had minimal change lesion. Four patients, all with nephrotic syndrome at diagnosis, progressed to end-stage renal disease. Of the 12 patients not presenting with nephrotic syndrome, none had chronic renal insufficiency at last follow-up. Kidney survival was 94% and 78% at 1 and 5 years, respectively, in all patients and 88% and 49% in those presenting with nephrotic syndrome.
Literatur
1.
Zurück zum Zitat Jennette JC, Hipp CG C1q Nephropathy (1985) A distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 103–110:1985 Jennette JC, Hipp CG C1q Nephropathy (1985) A distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 103–110:1985
2.
Zurück zum Zitat Jennette JC, Falk RJ (2004) C1q nephropathy. In Massry SG, Glassock RJ (eds) Textbook of nephrology, 4th edn. Lippincott-Williams & Wilkins, Philadelphia, pp 730–733 Jennette JC, Falk RJ (2004) C1q nephropathy. In Massry SG, Glassock RJ (eds) Textbook of nephrology, 4th edn. Lippincott-Williams & Wilkins, Philadelphia, pp 730–733
3.
Zurück zum Zitat Iskandar SS, Browning MC, Lorentz WB (1991) C1q nephropathy: a pediatric clinicopathologic study. Am J Kidney Dis 18:459–465 Iskandar SS, Browning MC, Lorentz WB (1991) C1q nephropathy: a pediatric clinicopathologic study. Am J Kidney Dis 18:459–465
4.
Zurück zum Zitat Markowitz GS, Schwimmer JA, Stokes BM, Nasr S, Siegle RL, Valeri AM, D’Agati VD (2003) C1q nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int 64:1232–1240 Markowitz GS, Schwimmer JA, Stokes BM, Nasr S, Siegle RL, Valeri AM, D’Agati VD (2003) C1q nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int 64:1232–1240
5.
Zurück zum Zitat Sharman A, Furness P, Feehally J (2004) Distinguishing C1q nephropathy from lupus nephritis. Nephrol Dial Transplant 19:1420–1426 Sharman A, Furness P, Feehally J (2004) Distinguishing C1q nephropathy from lupus nephritis. Nephrol Dial Transplant 19:1420–1426
6.
Zurück zum Zitat Shappell SB, Myrthil G, Fogo A (1997) An adolescent with relapsing nephritic syndrome: minimal-change disease versus focal-segmental glomerulosclerosis versus C1q nephropathy. Am J Kidney Dis 29:966–970 Shappell SB, Myrthil G, Fogo A (1997) An adolescent with relapsing nephritic syndrome: minimal-change disease versus focal-segmental glomerulosclerosis versus C1q nephropathy. Am J Kidney Dis 29:966–970
7.
Zurück zum Zitat Srivastava T, Chadha V, Taboada EM, Alon U (2000) C1q nephropathy presenting as rapidly progressive crescentic glomerulonephritis. Pediatr Nephrol 14:976–979 Srivastava T, Chadha V, Taboada EM, Alon U (2000) C1q nephropathy presenting as rapidly progressive crescentic glomerulonephritis. Pediatr Nephrol 14:976–979
8.
Zurück zum Zitat Ekim M, Ikinciogullari A, Berberoglu M, Tulunay O, Sencer H, Ozkaya N, Reisli I, Tumer N (2002) C1q nephropathy: a case with severe atopic dermatitis. Pediatr Nephrol 17:547–549 Ekim M, Ikinciogullari A, Berberoglu M, Tulunay O, Sencer H, Ozkaya N, Reisli I, Tumer N (2002) C1q nephropathy: a case with severe atopic dermatitis. Pediatr Nephrol 17:547–549
9.
Zurück zum Zitat National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents (1996) Update on the 1987 task force report on high blood pressure in children and adolescents. Pediatrics 98:649–658PubMed National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents (1996) Update on the 1987 task force report on high blood pressure in children and adolescents. Pediatrics 98:649–658PubMed
10.
Zurück zum Zitat Schwartz GL, Haycock GB, Edelmann CM, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263PubMed Schwartz GL, Haycock GB, Edelmann CM, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263PubMed
11.
Zurück zum Zitat Wyatt RJ, Julian BA, Bhathena DB, Mitchell BL, Holland NH, Malluche HH (1984) IgA nephropathy: presentation, clinical course, and prognosis in children and adults. Am J Kidney Dis 4:192–200 Wyatt RJ, Julian BA, Bhathena DB, Mitchell BL, Holland NH, Malluche HH (1984) IgA nephropathy: presentation, clinical course, and prognosis in children and adults. Am J Kidney Dis 4:192–200
12.
Zurück zum Zitat Lau KK, Gaber LW, Delos Santos NM, Fisher KA, Grimes SJ, Wyatt RJ (2004) Pediatric IgA nephropathy: clinical features at presentation and outcome for African-Americans and Caucasians. Clin Nephrol 62:167–172 Lau KK, Gaber LW, Delos Santos NM, Fisher KA, Grimes SJ, Wyatt RJ (2004) Pediatric IgA nephropathy: clinical features at presentation and outcome for African-Americans and Caucasians. Clin Nephrol 62:167–172
13.
Zurück zum Zitat Jennette JC, Hippe CG (1985) Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens. Am J Clin Pathol 83:415–420 Jennette JC, Hippe CG (1985) Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens. Am J Clin Pathol 83:415–420
14.
Zurück zum Zitat Jones E, Magil A (1982) Nonsystemic mesangiopathic glomerulonephritis with “full house” immunofluorescence. Am J Clin Pathol 78:29–34 Jones E, Magil A (1982) Nonsystemic mesangiopathic glomerulonephritis with “full house” immunofluorescence. Am J Clin Pathol 78:29–34
15.
Zurück zum Zitat Enriquez JL, Rajaraman S, Kalia A, Brouhard BH, Travis LB (1988) Isolated antibody-negative lupus nephropathy in young children. Child Nephrol Urol 9:340–346 Enriquez JL, Rajaraman S, Kalia A, Brouhard BH, Travis LB (1988) Isolated antibody-negative lupus nephropathy in young children. Child Nephrol Urol 9:340–346
16.
Zurück zum Zitat Wyatt RJ (1993) The complement system in IgA nephropathy and Henoch-Schönlein purpura: functional and genetic aspects. Contrib Nephrol 104:82–91 Wyatt RJ (1993) The complement system in IgA nephropathy and Henoch-Schönlein purpura: functional and genetic aspects. Contrib Nephrol 104:82–91
17.
Zurück zum Zitat Miyazaki R, Kuroda M, Akiyama T, Otani I, Tofuku Y, Takeda R (1984) Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy. Clin Nephrol 21:335–340 Miyazaki R, Kuroda M, Akiyama T, Otani I, Tofuku Y, Takeda R (1984) Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy. Clin Nephrol 21:335–340
18.
Zurück zum Zitat Kusunoki Y, Itami N, Tochimura H, Takekoshi Y, Nagasawa R (1987) Glomerular deposition of C4 cleavage fragment (C4d) and C4-binding protein in idiopathic membranous glomerulonephritis. Nephron 51:17–19 Kusunoki Y, Itami N, Tochimura H, Takekoshi Y, Nagasawa R (1987) Glomerular deposition of C4 cleavage fragment (C4d) and C4-binding protein in idiopathic membranous glomerulonephritis. Nephron 51:17–19
19.
Zurück zum Zitat Wyatt RJ, Kanayama Y, Julian BA, Negoro N, Sugimoto S, Hudson EC, Curd JG (1987) Complement activation in IgA nephropathy. Kidney Int 31:1019–1023 Wyatt RJ, Kanayama Y, Julian BA, Negoro N, Sugimoto S, Hudson EC, Curd JG (1987) Complement activation in IgA nephropathy. Kidney Int 31:1019–1023
20.
Zurück zum Zitat Mestecky J, Tomana M, Crowley-Nowick PA, Moldoveanu Z, Julian BA, Jackson S (1993) Defective galactosylation and clearance of IgA1 as a possible etiopathologic factor in IgA nephropathy. Contrib Nephrol 104:172–182 Mestecky J, Tomana M, Crowley-Nowick PA, Moldoveanu Z, Julian BA, Jackson S (1993) Defective galactosylation and clearance of IgA1 as a possible etiopathologic factor in IgA nephropathy. Contrib Nephrol 104:172–182
21.
Zurück zum Zitat Yoshikawa N, Iijima K, Shimomura M, Nakamura H, Ito H (1994) IgG-associated primary glomerulonephritis in children. Clin Nephrol 42:281–287 Yoshikawa N, Iijima K, Shimomura M, Nakamura H, Ito H (1994) IgG-associated primary glomerulonephritis in children. Clin Nephrol 42:281–287
Metadaten
Titel
C1q nephropathy: features at presentation and outcome
verfasst von
Keith K. Lau
Lillian W. Gaber
Noel M. Delos Santos
Robert J. Wyatt
Publikationsdatum
01.06.2005
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 6/2005
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-004-1810-8

Weitere Artikel der Ausgabe 6/2005

Pediatric Nephrology 6/2005 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.